FIBROGEN INC — Director's Dealing 2023

Mar 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-03-20

Reporting Person: Wettig Thane (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-20	Common Stock	G	2343	$0.00	Disposed	108310	Direct
2023-03-20	Common Stock	G	1000	$0.00	Acquired	1000	Indirect

Footnotes

F1: The share total in column 5 reflects ownership as of March 28, 2023.